HC Wainwright Reaffirms Buy Rating for OPKO Health (NASDAQ:OPK)
HC Wainwright restated their buy rating on shares of OPKO Health (NASDAQ:OPK – Free Report) in a report released on Wednesday, Benzinga reports. The firm currently has a $3.00 target price on the biotechnology company’s stock. A number of other analysts have also issued reports on the company. Barrington Research reissued an outperform rating and […]
More Stories
PepsiCo (NASDAQ:PEP) PT Raised to $185.00
PepsiCo (NASDAQ:PEP – Free Report) had its target price raised by JPMorgan Chase & Co. from $182.00 to $185.00 in...
PepsiCo (NASDAQ:PEP) PT Raised to $185.00
PepsiCo (NASDAQ:PEP – Free Report) had its target price raised by JPMorgan Chase & Co. from $182.00 to $185.00 in...
PepsiCo (NASDAQ:PEP) PT Raised to $185.00
PepsiCo (NASDAQ:PEP – Free Report) had its target price raised by JPMorgan Chase & Co. from $182.00 to $185.00 in...
The Real State of the U.S. Economy: Unemployment Figures Twice as High Under Biden-Harris Administration
By Stephen Zogopoulos, USNN World News As the Biden-Harris administration continues to tout economic recovery and low unemployment rates, a...
The Real State of the U.S. Economy: Unemployment Figures Twice as High Under Biden-Harris Administration
By Stephen Zogopoulos, USNN World News As the Biden-Harris administration continues to tout economic recovery and low unemployment rates, a...
The Real State of the U.S. Economy: Unemployment Figures Twice as High Under Biden-Harris Administration
By Stephen Zogopoulos, USNN World News As the Biden-Harris administration continues to tout economic recovery and low unemployment rates, a...